Real-time pharmacy alerts to help people with HIV stay on their antiretroviral medicines
Official title: RFA-PS-21-004: Using Real-time Prescription Data to Support HIV Care and Treatment Adherence in NYC
Funded at Amida Care INC. · NIH-11126510 · Data updated 2026-11-12
This project uses pharmacy insurance data to find people with HIV who miss ARV refills and connects them to timely support to stay on treatment.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Amida Care INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2022 |
| Project end | September 29, 2026 |
| Funding year | 2025 |
| Award (this year) | $1 |
| NIH project number | 5U01PS005221-04 |
| Project ID | NIH-11126510 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in New York City whose pharmacy or insurance data are captured by the partner network (for example, Amida Care members) are the ideal candidates.
✕Less likely to help
People who live outside the NYC service area, are not covered by the participating pharmacy/insurance systems, already pick up ARVs on time, or decline outreach are unlikely to benefit directly.
What this research studies
If your pharmacy claims show you missed an antiretroviral (ARV) pickup at 30 or 60 days, the program may identify this gap and arrange outreach. Partner organizations will use pharmacy claims, clinic visit claims, and lab data to track missed refills and recent viral load or CD4 results. Outreach can include reminders, counseling, help scheduling appointments, or other evidence-based supports to address reasons for missed doses. University and public health partners will monitor whether people re-engage in care, refill medications, and achieve viral suppression.
Why it matters
Potential benefit: If successful, this approach could reduce gaps in HIV treatment, improve adherence and viral suppression, and help people stay connected to care.
How similar studies have gone: Related Data-to-Care programs have shown promise in re-linking people with HIV to care, though real-time pharmacy-triggered outreach is a newer, less widely tested approach.
Where this research is happening
-
Amida Care INC.
New York, United States Active
Researchers
- Principal investigator: Antonios, Vera — Amida Care INC.
- Study coordinator: Antonios, Vera
Related research
Other NIH-funded projects on the same topics.
-
VS4A: A video program to help adolescents with HIV stay in care and take their meds
A video-based program designed for adolescents living with HIV in Malawi to help them stay in care and keep their viral load low, tested in a real-world clinic setting.
-
Real-time pharmacy alerts to help New Yorkers stay on HIV medicines
This project uses real-time pharmacy data to find and help people with HIV in New York City who miss antiretroviral refills at 30 or 60 days.
-
VS4A: A video program to help adolescents with HIV stick to treatment
A video-based program tailored for adolescents with HIV in Malawi aims to improve staying in care and sticking to ART by using engaging videos and conversations.
-
Integrated Navigation for Adherence and Care in HIV (INSTACARE)
A clinic-based team of community health workers helps Black adults with poorly controlled HIV stay adherent to treatment and connected to care in Miami-Dade County.
-
reSET for stimulant use in HIV care to boost treatment adherence
A 2-arm study will test an all-virtual stimulant use treatment added to HIV care to help people stay engaged in ART.
-
Technology Aided Strategies to Help Liver Transplant Patients Stick to Their Treatment
A new program uses technology to help people who have had a liver transplant take their medicines correctly and stay well.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.